Correspondence on 'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort'

Ann Rheum Dis. 2023 Feb;82(2):e32. doi: 10.1136/annrheumdis-2020-219409. Epub 2020 Nov 11.

Authors

Adeline Ruyssen-Witrand¹, Martin Soubrier², André Basch³, Marie-Elise Truchetet⁴, Raphaèle Seror⁵

Affiliations

¹ Purpan Teaching Hospital, Rheumatology, University Hospital Centre Toulouse, Toulouse, France adruyssen@hotmail.com.
² Rheumatology, G. Montpied Hospital, Clermont-Ferrand, France.
³ Clinique Protestante de Lyon, Lyon, France.
⁴ Rhumatologie, CHU Bordeaux, Bordeaux, France.
⁵ Rheumatology Department, Université Paris Sud, Hôpitaux Universitaires Paris-Sud, AP-HP, INSERM UMR 1184, Le Kremlin-Bicêtre, France.

PMID: 33177101
DOI: 10.1136/annrheumdis-2020-219409

No abstract available

Keywords: arthritis; biological therapy; epidemiology; health care; quality indicators; rheumatoid.

Publication types

Letter

MeSH terms

Arthritis, Rheumatoid* / epidemiology
COVID-19*
Humans
Pandemics
Rheumatic Diseases* / epidemiology
Switzerland